X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs VENUS REMEDIES - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD VENUS REMEDIES WYETH LTD/
VENUS REMEDIES
 
P/E (TTM) x 27.7 -788.7 - View Chart
P/BV x 5.3 0.2 2,318.9% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   VENUS REMEDIES
EQUITY SHARE DATA
    WYETH LTD
Mar-13
VENUS REMEDIES
Mar-16
WYETH LTD/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,044218 479.1%   
Low Rs81882 996.3%   
Sales per share (Unadj.) Rs298.6365.6 81.7%  
Earnings per share (Unadj.) Rs57.21.5 3,851.9%  
Cash flow per share (Unadj.) Rs58.437.9 154.0%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.5382.5 65.2%  
Shares outstanding (eoy) m22.7211.44 198.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.4 760.0%   
Avg P/E ratio x16.3101.0 16.1%  
P/CF ratio (eoy) x15.94.0 402.9%  
Price / Book Value ratio x3.70.4 951.6%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1571,717 1,232.5%   
No. of employees `0000.51.0 48.2%   
Total wages/salary Rs m400324 123.3%   
Avg. sales/employee Rs Th13,787.44,100.7 336.2%   
Avg. wages/employee Rs Th813.0318.0 255.6%   
Avg. net profit/employee Rs Th2,643.316.7 15,859.8%   
INCOME DATA
Net Sales Rs m6,7834,183 162.2%  
Other income Rs m35320 1,754.2%   
Total revenues Rs m7,1364,203 169.8%   
Gross profit Rs m1,617812 199.3%  
Depreciation Rs m27417 6.4%   
Interest Rs m6380 1.4%   
Profit before tax Rs m1,93835 5,520.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m63218 3,492.8%   
Profit after tax Rs m1,30117 7,650.0%  
Gross profit margin %23.819.4 122.9%  
Effective tax rate %32.651.6 63.3%   
Net profit margin %19.20.4 4,717.1%  
BALANCE SHEET DATA
Current assets Rs m6,9842,771 252.1%   
Current liabilities Rs m2,0561,931 106.4%   
Net working cap to sales %72.620.1 362.0%  
Current ratio x3.41.4 236.8%  
Inventory Days Days99125 79.4%  
Debtors Days Days2454 44.5%  
Net fixed assets Rs m2445,328 4.6%   
Share capital Rs m227114 198.6%   
"Free" reserves Rs m5,4414,177 130.3%   
Net worth Rs m5,6684,376 129.5%   
Long term debt Rs m251,911 1.3%   
Total assets Rs m7,9018,428 93.7%  
Interest coverage x353.31.1 32,343.6%   
Debt to equity ratio x00.4 1.0%  
Sales to assets ratio x0.90.5 173.0%   
Return on assets %16.54.7 351.1%  
Return on equity %22.90.4 5,906.5%  
Return on capital %34.06.6 515.9%  
Exports to sales %0.20-   
Imports to sales %36.320.5 177.1%   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465858 287.2%   
Fx inflow Rs m150-   
Fx outflow Rs m2,677858 311.9%   
Net fx Rs m-2,662-858 310.1%   
CASH FLOW
From Operations Rs m923469 196.9%  
From Investments Rs m31729 1,085.3%  
From Financial Activity Rs m-481-464 103.8%  
Net Cashflow Rs m75935 2,200.3%  

Share Holding

Indian Promoters % 0.0 32.9 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 0.2 6,277.8%  
FIIs % 7.2 0.6 1,241.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 66.4 45.8%  
Shareholders   21,978 20,121 109.2%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - NATCO PHARMA COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS